Abstract Library

#1363 Efficacy of Lutetium-177 DOTA Octreotate Peptide Receptor Radionuclide Therapy in Patients with Advanced Neuroendocrine Tumours and Carcinoid Syndrome Refractory to Somatostatin Analogues

Introduction: Somatostatin Analogues (SSAs) are considered the gold standard treatment in Neuroendocrine Tumours (NETs) and carcinoid syndrome.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Koffas A

Authors: Koffas A, Popat R, Dimitriou G, Quigley A, Navalkissoor S,

Keywords: PRRT, carcinoid syndrome,

#184 Somatostatin Analogues as a Therapeutic Option in a Series of 91 Patients with Gastric Carcinoids

Introduction: Gastric carcinoid tumors (GC) represent about 10-30% of carcinoid tumors and about 1% of all stomach neoplasms. They include three types : type 1 (70-85%), type 2 (5-10%) and type 3 (15-25%).

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: Basagiannis C, Angelopoulos T, Papadimitriou C, Geragotou T, Siakavellas S,

Keywords: gastric carcinoid, gastrin, Somatostatin analogues.,